We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




New Data Shows Most Patients Can Safely Undergo Contrast-Enhanced CT Scanning

By MedImaging International staff writers
Posted on 22 Sep 2014
Print article
According to new research, iodine-based contrast material injected intravenously (IV) to enhance computed tomography (CT) imaging can be safely used in most patients.

The study’s findings were published online September 9, 2014, in the journal Radiology. Of the 80 million or more CT scans performed each year in the United States, iodine-based contrast material is used in at least half to enhance computed tomography (CT) images, according to researcher Robert J. McDonald, MD, PhD, a radiology resident at the Mayo Clinic (Rochester, MN, USA).

According to Dr. McDonald, a small number of case reports from the 1950s, and more recently, retrospective studies deficient in appropriate control groups causally correlated the use of iodine-based contrast CT scans to kidney damage, a condition called contrast-induced nephropathy. “For nearly 60 years, physicians have worried about contrast-induced nephropathy when using iodinated contrast material, particularly for patients with impaired kidney function,” Dr. McDonald said. “Emerging evidence now suggests these concerns are likely vastly overestimated.”

Using advanced informatics tools, Dr. McDonald and colleagues studied data on patients who underwent pelvic, abdominal, and thoracic CT scans at the Mayo Clinic between 2000 and 2010. A study group of 21,346 patients included 10,673 patients who each underwent a contrast-enhanced CT exam and 10,673 patients who underwent a similar CT without intravenous contrast. The two groups were closely matched by demographic and clinical characteristics, including gender, race and preexisting conditions such as diabetes, congestive heart failure and acute renal disease.

The researchers analyzed the patient data for adverse events following the CT scans, including acute kidney injury, the need for emergency renal dialysis (in patients with no prior history of dialysis) and death within 30 days of contrast exposure.

The analysis revealed no significant difference in the rate of acute kidney injury between patients in the contrast group (4.8%, or 515 of 10,673) and the non-contrast group (5.1% or 544 of 10,673). More importantly, the rates of emergency dialysis and death in the 30-day window following CT examination were not substantially different between patients exposed to contrast and those who were not exposed. These findings were also noted among patients with compromised kidney function and high-risk conditions, such as congestive heart failure and diabetes, which are presumed to predispose a patient to kidney injury.

“These results challenge long-held assumptions regarding the presumed nephrotoxic risk of intravenous contrast material,” Dr. McDonald concluded. “We hope that our findings will help refine the safety profile of these contrast agents.”

Related Links:

Mayo Clinic


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Imaging Table
Stille imagiQ2
Mammography System
MAMMOVISTA B.smart
Compact C-Arm with FPD
Arcovis DRF-C R21

Print article

Channels

Ultrasound

view channel
Image: Structure of the proposed transparent ultrasound transducer and its optical transmittance (Photo courtesy of POSTECH)

Ultrasensitive Broadband Transparent Ultrasound Transducer Enhances Medical Diagnosis

The ultrasound-photoacoustic dual-modal imaging system combines molecular imaging contrast with ultrasound imaging. It can display molecular and structural details inside the body in real time without... Read more

Nuclear Medicine

view channel
Image: PET/CT of a 60-year-old male patient with clinical suspicion of lung cancer (Photo courtesy of EJNMMI Physics)

Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times

F-18 FDG-PET scans are a way to look inside the body using a special dye, and these scans can be either static or dynamic. Static scans happen 60 minutes after the dye is administered into the body, showing... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.